Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2572 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- HLA-A25 Antibody (HLA-Aw32)
- Antibody type
- Monoclonal
- Antigen
- Normal human peripheral blood lymphocytes of phenotype A1, Aw32, B7, B37, Cw-, Cw-, DR2, and DRw10 were used as the immunogen for the HLA-A25 antibody (HLA-Aw32).
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- CATA-1
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the HLA-A25 antibody (HLA-Aw32) at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
Serological mapping of HLA-epitopes with monoclonal antibodies and its interpretation by sequenced HLA-molecules.
The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
Serological expression after sequential double transfection with purified HLA-11 gene of mouse fibroblasts carrying human beta-2 microglobulin
Monoclonal antibody against HLA-Aw32 + A25. Is HLA-Aw32 an allele with no unique antigenic determinant?
HLA monoclonal antibody registry: second listing.
Ryschich E, Nötzel T, Hinz U, Autschbach F, Ferguson J, Simon I, Weitz J, Fröhlich B, Klar E, Büchler MW, Schmidt J
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Jan 15;11(2 Pt 1):498-504
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Jan 15;11(2 Pt 1):498-504
Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
Ryschich E, Cebotari O, Fabian OV, Autschbach F, Kleeff J, Friess H, Bierhaus A, Büchler MW, Schmidt J
Tissue antigens 2004 Dec;64(6):696-702
Tissue antigens 2004 Dec;64(6):696-702
Serological mapping of HLA-epitopes with monoclonal antibodies and its interpretation by sequenced HLA-molecules.
Harpprecht J, Olde K, Westphal E, Müller-Ruchholtz W
Tissue antigens 1989 Sep;34(3):170-8
Tissue antigens 1989 Sep;34(3):170-8
The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
Wan AM, Ennis P, Parham P, Holmes N
Journal of immunology (Baltimore, Md. : 1950) 1986 Dec 1;137(11):3671-4
Journal of immunology (Baltimore, Md. : 1950) 1986 Dec 1;137(11):3671-4
Serological expression after sequential double transfection with purified HLA-11 gene of mouse fibroblasts carrying human beta-2 microglobulin
Paul P, Lepage V, Sayagh B, Metzger J, Pla M, Boumsell L, Douay C, Cohen D, Colombani J, Dausset J, Degos L
Immunogenetics 1985 July;22(1):1-8
Immunogenetics 1985 July;22(1):1-8
Monoclonal antibody against HLA-Aw32 + A25. Is HLA-Aw32 an allele with no unique antigenic determinant?
Vilella R, Yague J, Vives J
Human immunology 1983 Jan;6(1):53-62
Human immunology 1983 Jan;6(1):53-62
HLA monoclonal antibody registry: second listing.
Colombani J, Lepage V, Kalil J
Tissue antigens 1983 Aug;22(2):97-106
Tissue antigens 1983 Aug;22(2):97-106
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin-fixed, paraffin-embedded human tonsil stained with HLA-Aw32 / HLA-A25 antibody (CATA-1).
